Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2
US11583564B2 · kind B2 · utility
1Cited by
8References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 2017 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | May 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and materials for intrathecal delivery of recombinant Adeno-associated virus 9 (rAAV9) encoding Methyl-CpG binding protein 2 (MECP2) are provided. Use of the methods and materials is contemplated, for example, for the treatment of Rett syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.